ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 174.02%
This Quarter Est. Return
1 Year Est. Return
+174.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$394M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
251
New
Increased
Reduced
Closed

Top Buys

1 +$27.5M
2 +$21.3M
3 +$21.3M
4
ETNB
89bio
ETNB
+$18.2M
5
LXEO icon
Lexeo Therapeutics
LXEO
+$9.21M

Top Sells

1 +$146M
2 +$18.6M
3 +$11M
4
MLYS icon
Mineralys Therapeutics
MLYS
+$8.49M
5
RAPT icon
RAPT Therapeutics
RAPT
+$7.1M

Sector Composition

1 Healthcare 87.56%
2 Financials 1.74%
3 Consumer Discretionary 0.24%
4 Communication Services 0.1%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NETD
226
DELISTED
Nabors Energy Transition Corp II
NETD
-39,900
NTRA icon
227
Natera
NTRA
$32.3B
-2,500
NXTC icon
228
NextCure
NXTC
$45.4M
-9,834
PLRX icon
229
Pliant Therapeutics
PLRX
$94M
-82,189
PYPD icon
230
PolyPid
PYPD
$64.5M
-103,950
RLMD icon
231
Relmada Therapeutics
RLMD
$324M
-130,000
RNXT icon
232
RenovoRx
RNXT
$31.4M
-19,889
SAGE
233
DELISTED
Sage Therapeutics
SAGE
-721,599
SHY icon
234
iShares 1-3 Year Treasury Bond ETF
SHY
$23.7B
-53,337
SNDX icon
235
Syndax Pharmaceuticals
SNDX
$1.66B
-10,000
STOK icon
236
Stoke Therapeutics
STOK
$1.72B
-27,285
STTK icon
237
Shattuck Labs
STTK
$153M
-102,948
SWTX
238
DELISTED
SpringWorks Therapeutics
SWTX
-24,082
THRD
239
DELISTED
Third Harmonic Bio
THRD
-622,873
TRVI icon
240
Trevi Therapeutics
TRVI
$1.71B
-30,000
VERV
241
DELISTED
Verve Therapeutics
VERV
-469,018
VIR icon
242
Vir Biotechnology
VIR
$844M
-250,000
XBI icon
243
State Street SPDR S&P Biotech ETF
XBI
$7.95B
0
STI icon
244
Solidion Technology
STI
$75.6M
0
UCFI
245
CN Healthy Food Tech Group
UCFI
-25,000
IROHR
246
DELISTED
Iron Horse Acquisitions Corp Right
IROHR
-12,320
JVSAR
247
DELISTED
JV SPAC Acquisition Corp. Right
JVSAR
-24,000
AAM.WS
248
AA Mission Acquisition Corp Warrants
AAM.WS
-505,099
OKUR
249
OnKure Therapeutics
OKUR
$38.5M
-10,000